Comparative evaluation of efficacy, tolerability and safety of 0.1% topical momethasone furoate and 0.05% desonide in the treatment of childhood atopic dermatitis;Avaliação comparativa da eficácia, tolerabilidade e segurança do furoato de mometasona a 0,1% tópico comparado à desonida 0,05% no tratamento da dermatite atópica em crianças

Anais Brasileiros de Dermatologia

Volumn 77, Issue 1, 2002, Pages 25-33

  Prado de Oliveira, Zilda Najjar ^a   Cucé, Luiz Carlos ^a   Arnone, Marcelo ^a  

^a NONE

Author keywords

Atopic dermatitis; Desonide; Topical application

Indexed keywords

CORTICOSTEROID; DESONIDE; MOMETASONE FUROATE;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; RANDOMIZED CONTROLLED TRIAL; SKIN ATROPHY; TOPICAL TREATMENT;

EID: 0036219386     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Perspectives in topical glucocorticosteroid therapy
2. Mometasone furoate ointment 0,1% vs hydrocortisone ointment 1% in psoriasis
3. Comparison of mometasone furoate 0,1% cream in the treatment of childhood atopic dermatitis
4. The use of topical steroids in psoriasis
5. Structure-activity relationships of a series of novel topical corticosteroids
6. Percutaneous absorption of topical steroids in children
7. Effect of potent topical steroids on plasma-cortisol levels of infants and children with eczema
8. Clinical investigations of mometasone furoate - A novel, nonfluorinated topical corticosteroid
9. Effect of a unique new synthetic corticosteroid, mometasone furoate ointment 0,1 percent and hydrocortisone ointment 1 percent, on adrenocortical function in psoriasis patients
10. Mometasone furoate ointment and cream 0,1 percent in treatment of psoriasis: Comparision with ointment and cream formulations of fluocinolone acetonide 0,025 percent and triamcinolone acetonide 0,1 percent
11. A clinical investigation of efficacy and safety of mometasone furoate ointment 0,1% vs betamethasone valerate ointment 0,1% in the treatment of psoriasis